drugset / Trial / NCT05046041
Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal
Phase 4
Completed
120 enrolled
Gynuity Health Projects
Bharatpur Eye Hospital · collabCenter for Research on Environment, Health and Population Activities · collabKIST Medical College and Teaching Hospital · collabLumbini Provincial Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This study seeks to evaluate the safety, acceptability and feasibility of an outpatient "day procedure" for medical abortion at 13-18 weeks gestation in two public sector facilities. It also seeks to document the roles of health workers in providing services related to later abortion care and to document the costs of this day procedure to the health system.
Timeline
- Start
- 2020-11-25
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 200 mg | Oral |
| Subject | Misoprostol | Other / unclassified | 400 ug | Other |
Indications
No indication recorded.